EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Frasers (FRAS LN) UK

Consumer Discretionary

Holland Advisors

Stepping into the light - share price jumps following the company’s FY update. Long-term bull Andrew Hollingworth thinks the rerating has only just begun. This is a company that has been through an extensive period of re-invention and investment. Its accounting has been uber prudent especially with reference to inventory and its store portfolio. Almost all investors have been referencing potential profitability vs. that recorded in this investment period. This has been an error. It has always been likely that post investment period margins would be better than its past peaks, due to discounting then and elevation now. TP £13.00+ (45%+ upside).

Edition: 141

- 05 August, 2022


Frasers Group (FRAS LN) UK

Consumer Discretionary

Holland Advisors

A forgotten and neglected share - few investors take the company seriously and fewer properly think through its market position and what it could become/the profits it could produce. Andrew Hollingworth discusses the margin recovery story underway and why he believes the price of the employee earn-out (£10.00) and Mike Murray’s new incentive (£15.00 in just 4-yrs) are realistic targets despite the startling difference when compared to today’s share price of 680p. FRAS remains a high conviction Buy.

Edition: 118

- 03 September, 2021